QoL, CIs, QALYs, and Individualized Rehabilitation: The Clinical and Practical Benefits of Regularly Assessing the Quality of Life of Adult Cochlear Implant Recipients.

asymmetrical hearing loss cochlear implant patient reported outcome measure quality of life rehabilitation single-side deafness

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
10 10 2023
Historique:
received: 03 05 2023
revised: 24 08 2023
accepted: 01 10 2023
medline: 30 10 2023
pubmed: 27 10 2023
entrez: 27 10 2023
Statut: epublish

Résumé

This study aimed to report quality of life (QoL) scores in unilateral cochlear implant (CI) users and to generate guidance for clinicians on using QoL measures to individualize CI counselling and rehabilitation and to increase access to CIs as a mode of rehabilitation. Participants (n = 101) were unilateral CI users with single-sided deafness (SSD; n = 17), asymmetrical hearing loss (AHL; n = 26), or bilateral hearing loss (Uni; n = 58). Generic QoL was assessed via the Health Utilities Index (HUI-3), and disease-specific QoL was assessed via the Speech, Spatial, and Qualities of Hearing scale (SSQ12) and Nijmegen CI Questionnaire (NCIQ) at preimplantation and at 6 and 12 months of CI use. All groups had significantly increased HUI-3 scores at both intervals. The SSD group showed significant benefit on the SSQ12 at visit 3, the AHL group showed significant benefit on the SSQ12 and most NCIQ subdomains at both intervals, and the Uni group showed significant benefit with both tests at both intervals. Unilateral CI recipients demonstrate improved QoL within the first 12 months of device use. Regular assessment with generic and disease-specific questionnaires has the potential to play an important role in personalizing treatment and possibly in increasing access to CI provision.

Identifiants

pubmed: 37887644
pii: ijerph20206906
doi: 10.3390/ijerph20206906
pmc: PMC10605987
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Otolaryngol Head Neck Surg. 2000 Dec;123(6):756-65
pubmed: 11112975
Otol Neurotol. 2021 Jun 1;42(5):706-712
pubmed: 33967247
Ear Hear. 2022 Nov-Dec 01;43(6):1605-1619
pubmed: 35994570
J Gen Intern Med. 2023 Feb;38(2):456-479
pubmed: 36385406
Patient. 2014;7(1):85-96
pubmed: 24271592
Otol Neurotol. 2022 Jun 1;43(5):e571-e577
pubmed: 35283464
Lang Speech Hear Serv Sch. 2013 Jan;44(1):73-88
pubmed: 22869089
Int J Environ Res Public Health. 2022 Feb 22;19(5):
pubmed: 35270201
Eur J Health Econ. 2022 Jul;23(5):763-779
pubmed: 34727294
Otol Neurotol. 2020 Aug;41(7):e795-e803
pubmed: 32558759
Laryngoscope. 2023 Apr;133(4):924-932
pubmed: 35792007
Laryngoscope. 2016 Sep;126(9):2110-5
pubmed: 26775283
Ear Hear. 2023 Mar-Apr 01;44(2):244-253
pubmed: 36303282
Adv Otorhinolaryngol. 2011;71:103-111
pubmed: 21389710
Cochlear Implants Int. 2022 May;23(3):139-147
pubmed: 34963418
Laryngoscope. 2016 Mar;126(3):699-706
pubmed: 26256441
Otol Neurotol. 2023 Mar 1;44(3):e155-e159
pubmed: 36649486
Ear Hear. 2015 Nov-Dec;36 Suppl 1:38S-47S
pubmed: 26731157
Ear Hear. 2021 Aug 09;43(2):379-397
pubmed: 34432671
Curr Opin Otolaryngol Head Neck Surg. 2022 Oct 1;30(5):303-308
pubmed: 36004791
Laryngoscope Investig Otolaryngol. 2016 Jun 06;1(3):42-48
pubmed: 28894803
JAMA Otolaryngol Head Neck Surg. 2019 May 1;145(5):422-430
pubmed: 30896742
PLoS One. 2021 Oct 13;16(10):e0257447
pubmed: 34644322
Int J Audiol. 2013 Jun;52(6):409-12
pubmed: 23651462
Laryngoscope. 2023 Sep;133(9):2362-2370
pubmed: 36254870
Ear Hear. 2019 Jul/Aug;40(4):766-781
pubmed: 30358655
Health Qual Life Outcomes. 2003 Oct 16;1:54
pubmed: 14613568
Otolaryngol Head Neck Surg. 2017 Feb;156(2):391
pubmed: 28145830
Ear Hear. 1995 Apr;16(2):176-86
pubmed: 7789669
Audiol Neurootol. 2021;26(2):61-75
pubmed: 32653882
Ear Hear. 2021 Jul-Aug 01;42(4):896-908
pubmed: 33735907
JAMA Otolaryngol Head Neck Surg. 2022 Sep 1;148(9):870-878
pubmed: 35951334
JAMA Otolaryngol Head Neck Surg. 2020 Feb 1;146(2):136-142
pubmed: 31830215

Auteurs

Luis Lassaletta (L)

Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain.
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, (CIBERER-U761), 28029 Madrid, Spain.

Miryam Calvino (M)

Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain.
Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, (CIBERER-U761), 28029 Madrid, Spain.

Isabel Sanchez-Cuadrado (I)

Department of Otorhinolaryngology, Hospital La Paz. IdiPAZ Research Institute, 28046 Madrid, Spain.

Piotr Henryk Skarzynski (PH)

Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland.

Katarzyna B Cywka (KB)

Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland.

Natalia Czajka (N)

Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland.

Justyna Kutyba (J)

Institute of Physiology and Pathology of Hearing, World Hearing Center, 05-830 Kajetany, Poland.

Dayse Tavora-Vieira (D)

Fiona Stanley Fremantle Hospitals Group, Perth 6150, Australia.

Paul Van de Heyning (P)

Department of Otorhinolaryngology, Antwerp University Hospital, 2650 Antwerp, Belgium.

Griet Mertens (G)

Department of Otorhinolaryngology, Antwerp University Hospital, 2650 Antwerp, Belgium.

Hinrich Staecker (H)

ENT Department, University of Kansas Medical Centre, Kansas City, KS 66160, USA.

Bryan Humphrey (B)

ENT Department, University of Kansas Medical Centre, Kansas City, KS 66160, USA.

Mario Zernotti (M)

Department of Otorhinolaryngology, Sanatorio Allende de Córdoba, Córdoba 5000, Argentina.

Maximo Zernotti (M)

Department of Otorhinolaryngology, Sanatorio Allende de Córdoba, Córdoba 5000, Argentina.

Astrid Magele (A)

ENT Department, Universitätsklinikum St. Pölten, 3100 St. Pölten, Austria.

Marlene Ploder (M)

ENT Department, Universitätsklinikum St. Pölten, 3100 St. Pölten, Austria.

Julia Speranza Zabeu (JS)

Hospital de Reabilitacão de Anomalias Craniofaciais da Universidade de Sao Paulo, Campus Bauru, Bauru 17012-230, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH